These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31493853)

  • 61. Cushing syndrome due to surreptitious glucocorticoid administration.
    Quddusi S; Browne P; Toivola B; Hirsch IB
    Arch Intern Med; 1998 Feb; 158(3):294-6. PubMed ID: 9472211
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cushing's syndrome in an 81-year-old patient treated with budesonide and amiodarone.
    Ahle GB; Blum AL; Martinek J; Oneta CM; Dorta G
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1041-2. PubMed ID: 11007145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids.
    Perry RJ; Findlay CA; Donaldson MD
    Arch Dis Child; 2002 Jul; 87(1):45-8. PubMed ID: 12089123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Iatrogenic Cushing's syndrome due to topical steroid abuse in a child with Psoriasis presenting as septicaemia.
    Sachdeva S; Arora P; Kulhari A; Sardana K
    Dermatol Ther; 2020 Jul; 33(4):e13514. PubMed ID: 32374062
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis.
    Yamauchi P
    Expert Rev Clin Immunol; 2017 Feb; 13(2):85-91. PubMed ID: 27967262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS.
    Putcharoen O; Do T; Avihingsanon A; Ruxrungtham K
    Drug Des Devel Ther; 2015; 9():5763-9. PubMed ID: 26566368
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey.
    Fredman R; Tenenhaus M
    Burns; 2013 Jun; 39(4):549-57. PubMed ID: 23092701
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Florid Cushing's syndrome and hirsutism induced by desoximetasone.
    Himathongkam T; Dasanabhairochana P; Pitchayayothin N; Sriphrapradang A
    JAMA; 1978 Jan; 239(5):430-1. PubMed ID: 621843
    [No Abstract]   [Full Text] [Related]  

  • 73. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ritonavir/Cobicistat-Induced Cushing Syndrome in HIV Patients Treated With Non-Oral Corticosteroids: A Call for Action?
    Cattaneo D; Giacomelli A; Pagani G; Filice C; Gervasoni C
    Am J Med Sci; 2021 Jan; 361(1):137-139. PubMed ID: 32958162
    [No Abstract]   [Full Text] [Related]  

  • 75. DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME AND OBESITY ASSOCIATED WITH STRIAE.
    SUMMERS VK; SHEEHAN HL; HIPKIN LJ; DAVIS JC
    Lancet; 1964 Nov; 2(7369):1079-82. PubMed ID: 14207891
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug-induced Cushing syndrome in a patient with ulcerative colitis after betamethasone enema: evaluation of plasma drug concentration.
    Tsuruoka S; Sugimoto K; Fujimura A
    Ther Drug Monit; 1998 Aug; 20(4):387-9. PubMed ID: 9712462
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS.
    Navarro J; Curran A
    HIV AIDS (Auckl); 2016; 8():175-182. PubMed ID: 27843352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cushing's syndrome secondary to topical corticosteroids abuse.
    Ermis B; Ors R; Tastekin A; Ozkan B
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):795-6. PubMed ID: 12780758
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
    Moltó J; Curran A; Miranda C; Challenger E; Santos JR; Ribera E; Khoo S; Valle M; Clotet B
    J Antimicrob Chemother; 2018 Mar; 73(3):732-737. PubMed ID: 29237008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir.
    Bartels H; Decosterd L; Battegay M; Marzolini C
    J Antimicrob Chemother; 2017 Sep; 72(9):2574-2577. PubMed ID: 28575323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.